IR 자료실
Date 2017-05-16 Count 415
Title CHA Biotech Unit CHA Healthcare Decides Financing of KRW 110 Billion
- CHA Biotech announces its subsidiary CHA Healthcare will receive KRW 110 billion in financing from Mirae Asset Partners Private Equity Fund IX.

- CHA Healthcare to issue KRW 86.4 billion of convertible preferred stocks and KRW 23.6 billion of convertible bonds.

- Mirae Asset Partners Private Equity Fund IX will acquire a 34 percent stake in the company. 

- CHA Biotech will own a 64.71 percent stake in the company.

- Mirae Asset Partners Private Equity Fund is a private equity investment firm based in Seoul, South Korea. Mirae Asset Partners Private Equity Fund IX manages private equity funds around over KRW 500 billion.

- CHA Healthcare currently focuses on exploring healthcare business opportunities in Singapore, Vietnam and other key markets across Southeast Asia. 
목록